The Hub for Disease-Specific Clinical Information

Recent News

Chronic Opioid Use in Older Colorectal Cancer Survivors
Do Endoscopist Characteristics Impact Colonoscopy Polyp Detection Rates?
Can HER2 Status Predict Response to EGFR-Targeted Therapies in Colorectal Cancer?
Triplet Therapy for BRAF V600E–Mutant Metastatic Colorectal Cancer
Colorectal Cancer’s Genetic Relationship to Other Cancers
Novel Approach to Predicting Adverse and Beneficial Effects of Immunologic Interventions
Is There a Role for Wnt/β‐catenin Modulation in Colorectal Cancer?
Exploring the Connection Between the Gut Microbiome and Colon Cancer
Researchers Identify New Genetic Variants Associated With Colorectal Cancer Risk
AACR 2019: Misdiagnosis, Advanced Disease Common in Young-Onset Colon Cancer
2019 ESMO TAT: Predicting Outcomes With Lung Immune Prognostic Index
Short-Course vs. Long-Course Chemoradiation Therapy for Rectal Cancer
Genetic Variants in Predicting Treatment Outcomes in Colorectal Cancer
Can Mutations Predict Survival After Pulmonary Metastasectomy for Colorectal Cancer?
Brazilian Study of Patients Older Than Age 80 With Colorectal Cancer
Novel Blood Test for Detecting Colorectal Adenomas
2019 GI Symposium: Adjuvant Chemotherapy Regimens for High-Risk Stage III Colon Cancer
2019 GI Symposium: BRCA1/2 Mutations and Subtype of Colorectal Cancer
Colorado Researchers Focus on Early-Onset Colorectal Cancer
2019 GI Symposium: Oxaliplatin-Induced Neurotoxicity in Colorectal Cancer
2019 GI Symposium: New Phase II/III Trial of Nivolumab in Metastatic Colorectal Cancer
2019 GI Symposium: Timing of Neoadjuvant Radiochemotherapy for Rectal Cancer
2019 GI Symposium: Does Prior Chemotherapy Affect Efficacy of Combination Regimens in Metastatic Colorectal Cancer?
2019 GI Symposium: Combination Immunotherapy for Refractory Colorectal Carcinoma
2019 GI Symposium: HIPEC in Patients With Colon Cancer at Risk of Peritoneal Metastases
FDA Grants Clearance for Direct-to-Consumer Genetic Test on Hereditary Colorectal Cancer Syndrome
2019 GI Symposium: Targeted Triplet Therapy for Metastatic Colorectal Cancer
FDA Grants Fast Track Designation to GRANITE-001 in Colorectal Cancer
Misdiagnosis of MSI or dMMR Status in Metastatic Colorectal Cancer
Sidedness, Tumor Bulk: Predictive Biomarkers of Late-Line Response in Colorectal Cancer?
Chemoradiotherapy for Squamous Cell Carcinoma of Anal Canal
Are Dietary Patterns Linked to Survival in Patients With Colorectal Cancer?
Intensity-Modulated vs. Conventional Radiation Therapy for Anal Cancer
Does Primary Tumor Location Affect Survival in RAS-Mutant Colorectal Cancer?
Novel Approach to Forecasting Response to Cetuximab in Colorectal Cancer
Reduced-Dose Combination Therapy in Geriatric Patients With Metastatic Colorectal Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.